InfuSystems Holdings (INFU)
(Real Time Quote from BATS)
$6.48 USD
+0.08 (1.25%)
Updated Sep 20, 2024 01:08 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for InfuSystems Holdings, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 126 | 110 | 102 | 97 | 81 |
Cost Of Goods | 63 | 47 | 42 | 39 | 34 |
Gross Profit | 63 | 63 | 60 | 59 | 47 |
Selling & Adminstrative & Depr. & Amort Expenses | 59 | 61 | 57 | 50 | 43 |
Income After Depreciation & Amortization | 4 | 2 | 3 | 9 | 4 |
Non-Operating Income | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 2 | 1 | 1 | 1 | 2 |
Pretax Income | 2 | 0 | 1 | 8 | 2 |
Income Taxes | 1 | 0 | 0 | -10 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 1 | 0 | 1 | 17 | 1 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 1 | 0 | 1 | 17 | 1 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 17 | 15 | 18 | 23 | 16 |
Depreciation & Amortization (Cash Flow) | 13 | 13 | 15 | 14 | 12 |
Income After Depreciation & Amortization | 4 | 2 | 3 | 9 | 4 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 21.65 | 21.55 | 22.05 | 21.72 | 20.84 |
Diluted EPS Before Non-Recurring Items | 0.04 | 0.00 | 0.06 | 0.80 | 0.07 |
Diluted Net EPS (GAAP) | 0.04 | 0.00 | 0.06 | 0.80 | 0.07 |
Fiscal Year end for InfuSystems Holdings, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 33.70 | 32.00 | 31.77 | 31.91 | 31.74 |
Cost Of Goods | 17.03 | 15.52 | 16.89 | 15.66 | 15.29 |
Gross Profit | 16.67 | 16.47 | 14.88 | 16.25 | 16.44 |
SG&A, R&D, and Dept/Amort Expenses | 14.81 | 17.32 | 13.63 | 14.55 | 15.19 |
Income After SG&A, R&D, and Dept/Amort Expenses | 1.86 | -0.85 | 1.25 | 1.70 | 1.25 |
Non-Operating Income | -0.06 | 0.00 | -0.02 | -0.01 | 0.00 |
Interest Expense | 0.48 | 0.46 | 0.50 | 0.56 | 0.62 |
Pretax Income | 1.31 | -1.30 | 0.73 | 1.12 | 0.63 |
Income Taxes | 0.59 | -0.19 | 0.66 | 0.43 | 0.20 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 0.72 | -1.11 | 0.07 | 0.69 | 0.44 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 0.72 | -1.11 | 0.07 | 0.69 | 0.44 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 21.71 | 21.23 | 21.76 | 21.72 | 21.60 |
Diluted EPS Before Non-Recurring Items | 0.03 | -0.05 | 0.00 | 0.03 | 0.02 |
Diluted Net EPS (GAAP) | 0.03 | -0.05 | 0.01 | 0.03 | 0.02 |